CTLA-4 antibody ipilimumab negatively affects CD4⁺ T-cell responses in vitro.

We observed slightly enhanced proliferative effects in the presence of antibodies to BTLA or LAG-3, but this effect did not reach statistical significance (Fig. 3 b).

also in 111,027 other papers